Latest News & PR

Nanologica utökar teknologiplattform

Nanologicas patentansökan med titeln ”Porous particles for use in treatment, prevention and/or postponement of degeneration of neurons and glia” har publicerats. Genom patentet söker Nanologica utöka sin teknologiplattform med användandet av tomma porösa partiklar för behandling av bland annat neurodegenerativa sjukdomar. Patentet avser skydda idén att använda tomma porösa partiklar för att adsorbera ämnen i

Read more »

Nanologica is a public company listed for trade on Spotlight Stock Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.

Presentation of Nanologica

Company presentation made by CEO Andreas Bhagwani on May 28, 2019.
For more videos about the Company as well as video presentations of interim reports, please refer to Investor Relations.